Immunotherapy beyond cellular therapy in Follicular Lymphoma: A case of
complete remission after failure of two CAR-T
- Adam Kase,
- Mohamed Kharfan Dabaja ,
- Andrew Donaldson,
- Jamie Elliott,
- Taimur Sher
Mohamed Kharfan Dabaja
Mayo Clinic Hospital Jacksonville
Author ProfileAbstract
Patients with relapsed follicular lymphoma who do not respond to CAR-T
have a poor outcome. We present a case of refractory follicular lymphoma
who relapsed after two CAR-T infusions and achieved a complete remission
after treatment with obinutuzumab and lenalidomide. This represents a
promising treatment option in the post-CAR-T setting.13 Jan 2022Submitted to Clinical Case Reports 17 Jan 2022Submission Checks Completed
17 Jan 2022Assigned to Editor
30 Jan 2022Reviewer(s) Assigned
09 Feb 2022Review(s) Completed, Editorial Evaluation Pending
16 Feb 2022Editorial Decision: Accept